Streptococcus bovis group and biliary tract infections: an analysis of 51 cases  by Corredoira, J. et al.
Streptococcus bovis group and biliary tract infections: an analysis of 51
cases
J. Corredoira1, M. P. Alonso2, F. Garcıa-Garrote2, M. J. Garcıa-Pais1, A. Coira2, R. Rabu~nal3, A. Gonzalez-Ramirez4, J. Pita2,
M. Matesanz3, D. Velasco2, M. J. Lopez-Alvarez1 and J. Varela1
1) Infectious Disease Unit, 2) Department of Clinical Microbiology, 3) Department of Internal Medicine and 4) Gastroenterology Unit, Hospital Lucus Augusti,
Lugo, Spain
Abstract
Streptococcus bovis is a well-known cause of endocarditis, but its role in other infections has not been well described. We analysed
prospectively all patients with biliary tract infections caused by S. bovis group during the period 1988–2011. We selected those cases
associated with cholangitis and cholecystitis, deﬁned according to Tokyo guidelines. Identiﬁcation of the strains was performed using the API
20 Strep and the GP card of the Vitek 2 system, and was conﬁrmed by molecular methods. Our series included 51 cases (30 cholangitis and
21 cholecystitis). The associated microorganisms were: Streptococcus infantarius (biotype II/1) 29 cases (57%), Streptococcus gallolyticus
subsp. pasteurianus (biotype II/2) 20 cases (39%) and Streptococcus gallolyticus subsp. gallolyticus (biotype I) two cases (4%). The only
difference found between S. infantarius and S. gallolyticus subsp. pasteurianus was a greater association of the ﬁrst with malignant strictures of
the bile ducts: 48% (14/29) versus 5% (1/20), p <0.001. Thirty-seven of the cases also had bacteraemia, causing 20% (37/185) of all S. bovis
bacteraemia, with differences between S. gallolyticus subsp. gallolyticus (2/112; 2%) and the other two microorganisms: S. infantarius and
S. gallolyticus subsp. pasteurianus (35/73; 48%; p <0.001). The vast majority of biliary tract infections due to S. bovis group are caused by
S. infantarius and S. gallolyticus subsp. pasteurianus (S. bovis biotype II), and nearly half of the bacteraemia due to these two species has a
biliary source (43% of the S. infantarius and 56% of S. gallolyticus subsp. pasteurianus).
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Introduction
The Streptococcus bovis group (SBG) includes several species
and subspecies of microorganisms that can cause humans
infections. This group was previously classiﬁed in two biotypes,
I and II (this latest divided in two subtypes (II/1 and II/2); the
current classiﬁcation comprises different species: Streptococcus
gallolyticus subsp. gallolyticus (formerly Streptococcus bovis bio-
type I), S. gallolyticus subsp. pasteurianus (formerly S. bovis
biotype II/2) and Streptococcus infantarius, subsp. coli and
subsp. infantarius (formerly S. bovis biotype II/1).
The SBG has been primarily associated with endocarditis
and colorectal neoplasia [1,2], This association with colorectal
neoplasms is higher than in controls [3], and this association is
stronger with advanced neoplasms [4], especially with S. gal-
lolyticus subsp. gallolyticus [5]. The SBG has also been linked to
osteoarticular infections, urinary tract infections, meningitis,
peritonitis and spontaneous bacteraemia in cirrhotic, neonatal
infections and non-colorectal cancer [6–11]. Over 20 years
ago, Ruoff et al. [12] reported the association between S. bovis
biotype II and biliary tract infections. Since then, this associ-
ation has received little attention [13–16]; the percentage of
SBG bacteraemia with biliary origin has been estimated in
several reports at between 0 and 38% [17–27]. However, the
features associated with this infection, risk factors, underlying
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diseases, and the relationship with the new taxonomic species
of SBG has not been well determined.
For this reason, the aim of this study is to describe clinical,
microbiological features and risk factors of the biliary tract
infections associated with SBG in our institution.
Materials and Methods
The study was performed at the Hospital Lucus Augusti
(formerly Hospital Xeral-Calde, Lugo), a large community
teaching hospital with 740 beds, serving a mixed urban and
rural area of 265 000 inhabitants, and is the reference centre
for two regional hospitals that provide health care to an area
of 118 000 inhabitants. Between 1 January 1988 and 31
December 2011, all adult patients with positive blood cultures
were followed prospectively. During this period we detected
11 750 bacteraemias, of which, 185 were caused by SBG
(1.6%). Of these 185 cases, 112 were identiﬁed as S. gallolyticus
subsp. gallolyticus, 27 as S. gallolyticus subsp. pasteurianus and 46
as S. infantarius, subsp. coli and subsp. infantarius.
Furthermore, since 2003 we have also followed all patients
with SBG isolated in any other type of sample other than
haemoculture. We isolated SBG in bile in 17 patients, which
was 3.4% of the microorganisms isolated in bile (495 cases).
All patients with biliary tract infection and SBG isolated in
blood cultures or bile were included in the study. The
diagnosis of acute cholangitis and acute cholecystitis was made,
according to Tokyo guidelines [28,29], on the basis of the
clinical ﬁndings in combination with laboratory data and
imaging ﬁndings.
Isolates were stored in skimmed milk DifcoTM (Becton-Dick-
inson, Sparks, MD, USA) at 70°C. Identiﬁcation of the strains
was performed using the API 20 Strep gallery and card Vitek 2
system GP (both from bioMerieux, Marcy l’Etoile, France). For
molecular identiﬁcation, the complete 16S rRNA gene
sequence was determined as previously described by Beck
et al. [23]. Antimicrobial susceptibility testing was performed
using the disc diffusion technique according to CLSI guidelines
[30] and the E-test method (AB Biodisk, Solna, Sweden),
following the manufacturer’s recommendations.
Results
General characteristics of the series
During the study period, SBG was isolated in 51 patients
diagnosed with biliary tract infection according to Tokyo
guidelines. The mean age of the patients was 73.6 years (range
44–93 years), and 65% were male. The biliary tract infections
diagnosed were: 30 cholangitis and 21 cholecystitis (Table 1).
The causes of cholangitis were: malignant biliary stricture in 17
cases [pancreatic cancer (eight cases), cholangiocarcinoma
(four cases), ampulloma (two cases), gastric cancer (two
cases), duodenal cancer (one case)]; choledocholithiasis in nine
cases, and benign strictures or ﬁstulas caused by previous
surgery in four cases. The causes of the cholecystitis in all 21
patients was cholelithiasis.
Clinical manifestations and complications
The most common clinical manifestations were fever (84%),
abdominal pain (63%) and jaundice (29%). Seventy-nine percent
of patients presented with leucocytosis. Major complications
were: abdominal or liver abscesses (11 cases), pancreatitis (ﬁve
cases), surgical wound infections (four cases), gallbladder
perforation with peritonitis (three cases) and septic shock
(three cases).
The most frequent associated co-morbidities were: cancer
(22 cases, 17 of them digestive non-colorectal, two prostate,
two breast, one leg sarcoma), diabetes mellitus (20 cases),
ischaemic heart disease (11 cases) and chronic obstructive
pulmonary disease (nine cases). Colorectal adenomas were
detected in four patients.
Five patients with biliary infection by SBG died (10%): two of
them from sepsis and the other three due to their underlying
disease (pancreatic cancer).
Treatment
Empirical antimicrobial treatment was appropriate in 87% of
patients. All isolates were susceptible to penicillin, ceftriaxone
and vancomycin, and 69% and 75% of them were susceptible to
clindamycin and levoﬂoxacin, respectively. Surgery was per-
formed in 15 cases (29%); any other drainage was carried out
in 17 cases (33%), and a biliary stent was placed or replaced in
ﬁve cases (10%).
Microbiological characteristics
Streptococcus bovis group organisms were isolated in 51 patients
with biliary infection: 34 from blood cultures, 14 from bile and
three in both samples. The SBG accounted for 3.3% of biliary
infections documented microbiologically. SBG was isolated
from polymicrobial infections in 30 patients (59%): in 18 cases
with two microorganisms and in 12 cases with three or more
microorganisms. SBG was isolated with other microorganisms
in 71% (10/14) of bile samples and in 54% (20/37) of
haemocultures. Most frequently associated microorganisms
were: Escherichia coli (24 cases) and Enterococccus spp. (11
cases). The only statistically signiﬁcant difference between the
polymicrobial biliary infections due to SBG compared with SBG
monomicrobial biliary infections was the lower percentage of
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abscesses found in monomicrobial biliary infections (1/21: 5%
versus 10/30: 33%; p <0.01).
After molecular identiﬁcation, the isolates were taxonom-
ically classiﬁed as follows: 29 as S. infantarius (57%), 20 as
S. gallolyticus subsp. pasteurianus (39%) and two as S. gallolyticus
subsp. gallolyticus (4%). When comparing the clinical charac-
teristics of the infections caused by S. infantarius with those
caused by S. gallolyticus subsp. pasteurianus, the only difference
found was the stronger association of the former with
malignant strictures of the bile duct (14 of 29, 48% versus 1
of 20, 5%, p <0.001).
Biliary bacteraemia caused by S. bovis group
During the period 1988–2011 there were 1109 cases of
bacteraemias of biliary origin in our hospital. Of these, 37 were
caused by SBG (3.3%). We compared 1072 biliary bacterae-
mias caused by microorganisms other than SBG with the 37
cases of SBG bacteraemias of biliary origin, to analyse the risk
factors associated with these infections. The demographic
characteristics, clinical manifestation, complications, co-mor-
bidity and mortality were not different between the two
groups, except for a higher percentage of polymicrobial
bacteraemia in the SBG with respect to the general group
(51% (19/37) vs 20% (219/1072); p <0.0001) and a higher
association with malignant pathology of the biliary tract in the
subgroup of patients with bacteraemia caused by S. infantarius.
Hence, biliary bacteraemia in our hospital was associated with
neoplasia in 279 of 1091 cases (26%) and S. infantarius
bacteraemia was associated with 13 of 20 cases (65%,
p <0.0001).
The 37 cases of biliary bacteraemia caused by SBG
accounted for 20% (37/185) of all S. bovis bacteraemia. We
compared 148 non-biliary SBG bacteraemia with the 37 cases
of SBG bacteraemia with biliary origin and the main differences
between the two groups are presented in Table 2.
In all the bacteraemia due to SBG, when we analysed the
percentage with a biliary source, we found signiﬁcant differ-
ences among the three subspecies. Only two (2%) of the 112
bacteraemias caused by S. gallolyticus subsp. gallolyticus were of
biliary origin, whereas higher frequencies were found both in
S. infantarius, 20 of 46 cases (43%), and S. gallolyticus
subsp. pasteurianus, 15 of 27 cases (56%); p <0.0001 in both
cases.
Seventeen of the 37 patients with SBG bacteraemia (one
with S. gallolyticus subsp. gallolyticus, four with S. infantarius and
12 with S. gallolyticus subsp. pasteurianus) underwent colonos-
copy. In the other 20 patients a colonoscopy was not
performed either because of non-colorectal cancer (16 cases),
or because the patient was dead or had a bad prognosis from
co-morbidities (four cases). Colorectal adenomas were
TABLE 1. Characteristics of the bil-
iary tract infections caused by
Streptococcus bovis group
Cholecystitis
(n = 21) (%)
Cholangitis
(n = 30) (%) p
Total
(n = 51) (%)
Age (mean in years) 77.6 72.9 NS 73.6
Sex (male) 14 (67) 19 (63) NS 33 (65)
Underlying diseases
Diabetes mellitus 6 (29) 14 (47) NS 20 (39)
Cancer 3 (14) 19 (63) 0.001 22 (43)
Ischaemic heart disease 4 (19) 7 (23) NS 11 (22)
Chronic obstructive pulmonary disease 5 (24) 4 (13) NS 9 (18)
Biliary disease
Benign
Lithiasis 21 (100) 9 (30) 0.000 30 (59)
Other 0 4 (13) NS 4 (8)
Malignant
Biliary–pancreatic 0 14 (47) 0.001 14 (27)
Gastroduodenal 0 3 (10) NS 3 (6)
Nosocomial infections 3 (14) 7 (23) NS 10 (20)
Type of infection
Monomicrobial 8 (38) 14 (47) NS 22 (43)
Polymicrobial 13 (62) 16 (53) NS 29 (57)
Clinical manifestations
Fever 15 (71) 28 (93) NS 43 (84)
Abdominal pain 20 (95) 12 (40) 0.000 32 (63)
Jaundice 3 (14) 12 (40) NS 15 (29)
Complications
Gangrenous cholecystitis 6 (29) 0 0.007 6 (12)
Abscess 9 (43) 2 (7) 0.006 11 (22)
Peritonitis 3 (14) 0 NS 3 (6)
Shock 3 (14) 0 NS 3 (6)
Pancreatitis 3 (14) 2 (7) NS 5 (10)
Surgical wound infection 4 (19) 0 0.05 4 (8)
Mortality 1 (5) 4 (13) NS 5 (10)
Isolation site
Haemocultures 6 (29) 28 (93) 0.000 34 (67)
Bile 12 (57) 2 (7) 0.000 14 (27)
Haemocultures and bile 3 (14) 0 NS 3 (6)
Microorganism
S. gallolyticus subsp. gallolyticus 0 2 (7) NS 2 (4)
S. infantarius 12 (57) 17 (57) NS 29 (57)
S. gallolyticus subsp pasteurianus 9 (43) 11 (37) NS 20 (39)
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detected in four patients (one with S. gallolyticus subsp. gallo-
lyticus, one with S. infantarius and two with S. gallolyticus
subsp. pasteurianus).
Discussion
There are few reported cases of biliary tract infection caused
by SBG [13–16]. A possible explanation is that in previous
publications about a-haemolytic streptococci, the bacteria
were rarely identiﬁed to the species level in intrabdominal
samples and, in studies about group D streptococci, both
enterococci and SBG were often grouped together [31–35].
However, even when performing an accurate identiﬁcation,
the percentage of SBG in biliary tract infections is <1% [36]. In
the few reports that analysed SBG in samples other than blood
cultures, the isolations in bile were scarce, ranging from 0 to
2% [37,38].
We have identiﬁed all SBG isolates in different clinical
specimens over the study period and, among the patients with
biliary tract infections, SBG represents a small percentage of
the isolates from blood cultures and bile. However, in our
institution biliary origin is the second commonest cause of SBG
bacteraemia after endocarditis. This could be explained
because SBG is able to grow in bile [39,40], in contrast to
most of the a-haemolytic streptococci.
If we analyse only S. infantarius and S. gallolyticus subsp. pas-
teurianus (formerly S. bovis biotype II) bacteraemia, 48% are of
biliary origin; however, bacteraemia caused by S. gallolyticus
subsp. gallolyticus is very rarely of biliary origin [5,12,21,24,27].
The different association of SBG species with biliary tract
infections could explain the differences found in several studies
of SBG bacteraemia, in which the bacteraemia of biliary origin
ranges between 0 and 38% depending on the percentage of
cases involving S. gallolyticus subsp. gallolyticus or the other
species [12,20–27].
Clinical features and complications of these infections do
not appear to be different from those caused by other
microorganisms that are frequently isolated in bile, we have
not found differences between SBG monomicrobial and
polymicrobial infections (Table 1), except in the lower
tendency of SBG to cause abscesses. In fact, there are few
reports of abscesses caused by SBG [41,42].
Little is known about the characteristics of biliary infections
caused by SBG. To our knowledge there is only one article
reported from Hong Kong that analysed this subject [20]; in
this report the authors comment that the association of biliary
tract disease with S. bovis bacteraemia was due to a high
incidence of biliary sepsis in their geographical area due to the
endemic parasitism of the biliary tract by Clonorchis sinensis; in
their report most of the isolates were S. gallolyticus subsp. pas-
teurianus. In our patients, gallstones and malignant strictures of
the biliary tract were the most frequent predisposing factors,
with strong association with S. infantarius and S. gallolyticus
subsp. pasteurianus. We also found a strong association
between S. infantarius and malignant neoplasm of the bile duct
and pancreas, as has been referred to in a previous report [11].
We conclude that SBG is a rare cause of biliary tract
infection, although if we consider all infections caused by this
group, the biliary source is one of the most frequent, with a
different percentage depending on the species. Streptococcus
gallolyticus subsp. gallolyticus bacteraemia rarely has a biliary
source, whereas almost half of the former S. bovis biotype II
bacteraemia (both S. infantarius and S. gallolyticus subsp. pas-
teurianus) have this origin. Streptococcus infantarius seems to be
associated with biliary–pancreatic cancer whereas S. gallolyticus
subsp. pasteurianus is associated with benign biliary tract
disease.
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